Inscription Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Inscription Capital's VRTX Position: Q2 2026 in Review
Inscription Capital increased its Vertex Pharmaceuticals (VRTX) stake by 172% in Q2 2026, buying an estimated $397K and bringing the position to 1,415 shares worth $703K. The position accounts for 0.06% of the portfolio, ranked #292.
Inscription Capital first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Inscription Capital held 1,415 shares of Vertex Pharmaceuticals worth $703K as of Q2 2026.
- Inscription Capital bought 895 Vertex Pharmaceuticals shares in Q2 2026, an estimated $397K.
- Vertex Pharmaceuticals made up 0.06% of Inscription Capital's portfolio in Q2 2026, its #292 holding.
- Inscription Capital first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.